Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03786094
Title Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
Acronym FORTRESS
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Polyphor Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | CZE | BRA | BEL | ARG


No variant requirements are available.